KA-PHARMA

Sint-Jans-Molenbeek ·KBO/BCE: BE 1005.869.016

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	92.8%	53.7%	better than 95% of 3165 sector peers
Net result	€106k	€18k	better than 93% of 3164 sector peers
Equity	€109k	€40k	better than 78% of 3167 sector peers
Gross operating margin	€107k	€36k	better than 85% of 3164 sector peers
Staff costs	€76	€22k	higher than 7% of 479 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€117k
Fixed assets	21/28	€1k
Tangible fixed assets	22/27	€1k
Current assets	29/58	€116k
Amounts receivable within one year	40/41	€94k
Cash & bank	54/58	€22k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€117k
Equity	10/15	€109k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€106k
Amounts payable	17/49	€9k
Amounts payable within one year	42/48	€9k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€107k
Operating result	9901	€106k
Result before taxes	9903	€106k
Net result for the period	9904	€106k
Result to be appropriated	9905	€106k

Summary